Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743402 · ClinicalTrials.gov registry record · NA
Strategies to Improve Pain and Enjoy Life
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT03743402: Completed NA study, sponsored by University of Washington.
NCT03743402 is a NA study that has completed, run by University of Washington. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03743402, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
In the Strategies to Improve Pain and Enjoy Life (STRIPE) study, the effectiveness of a multicomponent intervention will be tested, compared with usual care, on opioid dose and pain outcomes among patients on high dose (≥ 40 mg morphine equivalent dose) long-term opioid therapy in a randomized controlled trial. This intervention will have 4 components: a) telephone-delivered evidence-based pain self-management training, b) web-based video of successfully tapered patients with motivational interviewing debriefing, c) a voluntary, self-paced opioid taper, and d) opioid and non-opioid prescribing guidance for the patient's primary care provider.
Primary Outcome
Average over the prior 30 days of the prescribed daily morphine milligram equivalents (MME).
Interventions
- OTHER usual care
- BEHAVIORAL Pain self-management training
- BEHAVIORAL video education, motivational interviewing
- BEHAVIORAL voluntary self-paced opioid taper
- BEHAVIORAL prescribing guidance for primary care provider
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2022-01-27 |
| Phase | NA |
What the finished NCT03743402 record still lists
NCT03743402 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 5 interventions - of which usual care is the first listed.
NCT03743402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03743402 about?
NCT03743402 is a clinical study titled "Strategies to Improve Pain and Enjoy Life". In the Strategies to Improve Pain and Enjoy Life (STRIPE) study, the effectiveness of a multicomponent intervention will be tested, compared with usual care, on opioid dose and pain outcomes among patients on high dose (≥ 40 mg morphine equivalent dose) long-term opioid therapy in a randomized contr...
What is the current status of trial NCT03743402?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2019-04-04. Estimated completion is 2022-01-27.
What interventions are being tested in trial NCT03743402?
The interventions under investigation include: usual care (OTHER), Pain self-management training (BEHAVIORAL), video education, motivational interviewing (BEHAVIORAL), voluntary self-paced opioid taper (BEHAVIORAL), prescribing guidance for primary care provider (BEHAVIORAL).
Who is sponsoring clinical trial NCT03743402?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03743402's enrollment target sits among peer trials
153 656th of 2000 higher than 1,343 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI